Ferox 500 mg/10 ml (IV Injection or Infusion)
10 ml vial: ৳ 700.00
Medicine Details
Category | Details |
---|---|
Generic | Ferric carboxymaltose |
Company | Aci limited |
Also available as |
Indications
- Treatment of iron deficiency anaemia in adult patients with intolerance to oral iron
- Treatment of iron deficiency anaemia in adult patients with non-dialysis dependent chronic kidney disease
Description
Colloidal iron (III) hydroxide in complex with Carboxymaltose, a Carbohydrate polymer that releases iron
Dosage & Administration
- Stepwise approach to determining individual iron need
- Calculation and administration of the iron dose(s)
- Post-iron repletion assessments
Interaction
Formal drug interaction studies not performed
Contraindications
- Hypersensitivity to the active substance or any of its excipients
- Known serious hypersensitivity to other parenteral iron products
- Anaemia not attributed to iron deficiency or evidence of iron overload or disturbances in the utilisation of iron
Side Effects
- Most common: nausea, headache, dizziness, hypertension, injection site reactions
- Uncommon: hypersensitivit, dysgeusia, tachycardia, hypotension, flushing, dyspnoea, abdominal pain, constipation, diarrhea, Pruritus, urticaria, etc.
- Rare: anaphylactoid reactions, loss of consciousness, anxiety, phlebitis, syncope, etc.
Pregnancy & Lactation
Benefit/risk evaluation required before use during pregnancy, treatment confined to second and third trimester if benefit outweighs potential risk
Precautions & Warnings
- Serious hypersensitivity reactions reported, monitor for signs and symptoms of hypersensitivity
- Transient elevations in systolic blood pressure, monitor patients for hypertension following each administration
- In the 24 hours following administration, laboratory assays may overestimate serum iron and transferrin bound iron
Use in Special Populations
- Single maximum daily injection dose of 200 mg iron not to be exceeded in haemodialysis-dependent chronic kidney disease patients
- Not recommended in children under 14 years
Overdose Effects
Excessive dosages may lead to accumulation of iron in storage sites potentially leading to hemosiderosis, monitor iron parameters and consider use of an iron chelator
Therapeutic Class
Parenteral Iron Preparations
Storage Conditions
Store below 30°C in a cool, dry place, away from light, and out of reach of children
Related Brands
- Ferisen 750 mg/15 ml (IV Injection or Infusion) - healthcare-pharmaceuticals-ltd
- Jectofer 500 mg/10 ml (IV Injection or Infusion) - globe-pharmaceuticals-ltd
- Carbofer 500 mg/10 ml (IV Injection or Infusion) - chemist-laboratories-ltd
- Ferox 750 mg/15 ml (IV Injection or Infusion) - aci-limited
- Xefer 1 gm/20 ml (IV Injection or Infusion) - ziska-pharmaceuticals-ltd